IL116469A0 - 2-Chloro-2`-deoxyadenosine s oution - Google Patents

2-Chloro-2`-deoxyadenosine s oution

Info

Publication number
IL116469A0
IL116469A0 IL11646995A IL11646995A IL116469A0 IL 116469 A0 IL116469 A0 IL 116469A0 IL 11646995 A IL11646995 A IL 11646995A IL 11646995 A IL11646995 A IL 11646995A IL 116469 A0 IL116469 A0 IL 116469A0
Authority
IL
Israel
Prior art keywords
oution
deoxyadenosine
chloro
cda
optionally
Prior art date
Application number
IL11646995A
Other languages
English (en)
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of IL116469A0 publication Critical patent/IL116469A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11646995A 1994-12-22 1995-12-20 2-Chloro-2`-deoxyadenosine s oution IL116469A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36208394A 1994-12-22 1994-12-22

Publications (1)

Publication Number Publication Date
IL116469A0 true IL116469A0 (en) 1996-03-31

Family

ID=23424634

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11646995A IL116469A0 (en) 1994-12-22 1995-12-20 2-Chloro-2`-deoxyadenosine s oution

Country Status (15)

Country Link
US (1) US5681822A (xx)
EP (1) EP0801571B1 (xx)
JP (1) JPH10512549A (xx)
AT (1) ATE223221T1 (xx)
CA (1) CA2208484C (xx)
CZ (1) CZ194297A3 (xx)
DE (1) DE69528080T2 (xx)
DK (1) DK0801571T3 (xx)
ES (1) ES2182920T3 (xx)
HU (1) HUT77928A (xx)
IL (1) IL116469A0 (xx)
PL (1) PL321431A1 (xx)
PT (1) PT801571E (xx)
WO (1) WO1996019230A1 (xx)
ZA (1) ZA9510924B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations
DK1610822T4 (en) * 2003-04-02 2019-01-14 Ares Trading Sa Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant
CA2526099C (en) * 2003-06-20 2013-02-05 Ares Trading Sa Freeze-dried fsh / lh formulations
FR2873695A1 (fr) * 2004-07-30 2006-02-03 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
SG160391A1 (en) 2004-12-22 2010-04-29 Merck Serono Sa Cladribine regimen for treating multiple sclerosis
US9925151B2 (en) 2006-05-24 2018-03-27 Merck Serono Sa Cladribine regimen for treating multiple sclerosis
EP2343074A1 (en) 2009-12-23 2011-07-13 Merck Serono S.A. Use of purine analogues for treating airway diseases
BR112020010282A2 (pt) 2017-11-24 2020-11-17 Merck Patent Gmbh regime de cladribina para uso no tratamento de formas progressivas de esclerose múltipla
JP2023541877A (ja) 2020-09-10 2023-10-04 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 自己免疫障害の処置のための新規の処置レジメン
EP4302091A1 (en) 2021-03-03 2024-01-10 Ares Trading S.A. Improved treatment methods using dmds for the treatment of autoimmune diseases, and biomarker for predicting and/or optimising said treatment methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826823A (en) * 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4719295A (en) * 1985-12-31 1988-01-12 Warner-Lambert Company Compound 2-iodo-2'-deoxyadenosine
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US4908441A (en) * 1988-07-19 1990-03-13 Warner-Lambert Company Deoxyadenosine compounds and methods of making and using the same
US5208327A (en) * 1991-12-18 1993-05-04 Ortho Pharmaceutical Corporation Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
WO1993023058A1 (en) * 1992-05-19 1993-11-25 The Scripps Research Institute Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia

Also Published As

Publication number Publication date
ZA9510924B (en) 1997-06-23
CZ194297A3 (en) 1997-10-15
JPH10512549A (ja) 1998-12-02
DK0801571T3 (da) 2003-01-06
EP0801571B1 (en) 2002-09-04
PT801571E (pt) 2002-12-31
DE69528080T2 (de) 2003-06-05
DE69528080D1 (de) 2002-10-10
WO1996019230A1 (en) 1996-06-27
ES2182920T3 (es) 2003-03-16
ATE223221T1 (de) 2002-09-15
EP0801571A1 (en) 1997-10-22
HUT77928A (hu) 1998-11-30
CA2208484A1 (en) 1996-06-27
CA2208484C (en) 2008-09-23
PL321431A1 (en) 1997-12-08
US5681822A (en) 1997-10-28

Similar Documents

Publication Publication Date Title
IL116468A0 (en) 2-Chloro-2`-deoxyadenosine solution
HK1026363A1 (en) Ophthalmic compositions including glycerin and propylene glycol
MY121360A (en) Clear cleansing detergent systems.
EG20045A (en) Hair conditioning shampoo compositions with silicone conditioning agent
ZA974871B (en) Concentrated liquid formulations.
BR9708980A (pt) Aperfeiçoamento das taxas de implantação após fertilização invitro
AP9901534A0 (en) Pharmaceutical formulations.
ZA976777B (en) Anthelmintic formulations.
ZA984029B (en) Acitivity enhancement of ferulic acid with dimethyl isosorbide in cosmetic compositions.
IL116469A0 (en) 2-Chloro-2`-deoxyadenosine s oution
MX203624B (es) Composiciones cosmeticas para el autobronceado de la piel, a base de dihidroxiacetona, alquilpoliglucosidos y alcoholes grasos.
PT932397E (pt) Formulacoes em aerossol medicinais compreendendo budesonida
ZA973642B (en) DNA vaccine formulations.
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
ITTO910787A1 (it) Amplificatore di potenza, in particolare di tipo audio.
JO1907B1 (en) Dissolved compounds of 2-chloro-2-dioxin adenosine
HK1007867A1 (en) Gel cleanser composition.
ZA200109738B (en) Cosmetic skin care compositions containing cumic alcohol.
JO1908B1 (en) Static compounds of 2-chloro-2-dioxin adenosine
CA2208241A1 (en) Stable solutions of 2-chloro-2'-deoxyadenosine formulations
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
ITRM920723A1 (it) Procedimento per l'impiego di scorie schiumose nella produzione di acciai inossidabili.
ITPI960018A0 (it) Fascia di protezione amovibile per le aste delle sedie o simili
ZA972387B (en) Pharmaceutical formulations.
IT1288577B1 (it) Struttura di supporto, in particolare composita da attacchi per monosci